EPD Biotherapeutics Overview
- Year Founded
-
2021
- Status
-
Acquired/Merged
- Employees
-
15
- Latest Deal Type
-
M&A
EPD Biotherapeutics General Information
Description
Operator of a biotechnology company intended to provide therapies for protein degradation treatments. The company uses antibody and protein binders to overcome the limitations of existing low-molecular compound-based targeted therapeutics, enabling doctors to help patients suffering from conditions caused by certain genetic diseases.
Contact Information
Website
www.epdbio.comCorporate Office
- Room 1207, Daeryung Post Tower 2
- Digital-ro 306, Guro-gu
- Seoul, 08378
- South Korea
Corporate Office
- Room 1207, Daeryung Post Tower 2
- Digital-ro 306, Guro-gu
- Seoul, 08378
- South Korea
EPD Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 01-Oct-2024 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Feb-2024 | Completed | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | 01-Oct-2023 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Nov-2022 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC | 01-Jun-2022 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 01-Oct-2021 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 01-Oct-2021 | Completed | Pre-Clinical Trials |
EPD Biotherapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
EPD Biotherapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
EPD Biotherapeutics Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FuturePlay | Venture Capital | Minority | ||
| Hana Ventures | Corporate Venture Capital | Minority | ||
| Innocube | Accelerator/Incubator | Minority | ||
| Korea Startup/Biopharma Acceleration Program | Accelerator/Incubator | Minority | ||
| Medytox Venture Investment | Corporate Venture Capital | Minority |
EPD Biotherapeutics FAQs
-
When was EPD Biotherapeutics founded?
EPD Biotherapeutics was founded in 2021.
-
Where is EPD Biotherapeutics headquartered?
EPD Biotherapeutics is headquartered in Seoul, South Korea.
-
What is the size of EPD Biotherapeutics?
EPD Biotherapeutics has 15 total employees.
-
What industry is EPD Biotherapeutics in?
EPD Biotherapeutics’s primary industry is Biotechnology.
-
Is EPD Biotherapeutics a private or public company?
EPD Biotherapeutics is a Private company.
-
What is EPD Biotherapeutics’s current revenue?
The current revenue for EPD Biotherapeutics is .
-
How much funding has EPD Biotherapeutics raised over time?
EPD Biotherapeutics has raised $3.47M.
-
Who are EPD Biotherapeutics’s investors?
FuturePlay, Hana Ventures, Innocube, Korea Startup/Biopharma Acceleration Program, and Medytox Venture Investment are 5 of 7 investors who have invested in EPD Biotherapeutics.
-
When was EPD Biotherapeutics acquired?
EPD Biotherapeutics was acquired on 01-Oct-2024.
-
Who acquired EPD Biotherapeutics?
EPD Biotherapeutics was acquired by Genexine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
